Vimarsana
Biggest News Aggregation in the World

Page 2 - Scienta Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scienta Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scienta Communications Today - Breaking & Trending Today

Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer's Disease - Vimarsana News

Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer's Disease

Results Show Positive Treatment Effect of CT1812 on Global and Regional Brain Activity Management Holding Webcast Conference Call at 8:00am ET Today NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-st...

Cognition Therapeutics to Host Call and Webcast to Discuss - Vimarsana News

Cognition Therapeutics to Host Call and Webcast to Discuss

Call and webcast will take place at 8:00am ET...

New Data Demonstrating Stable Biochemical and Symptom Levels with Two-Years of Oral Paltusotine Administration Presented at ENDO 2023 - Vimarsana News

New Data Demonstrating Stable Biochemical and Symptom Levels with Two-Years of Oral Paltusotine Administration Presented at ENDO 2023

Early-Stage Candidates for Primary Hyperparathyroidism and Thyroid Eye Disease Also Featured Crinetics' Founder & CEO, Scott Struthers Accepted John D. Baxter Prize for Entrepreneurship from... | June 21, 2023

Crinetics to Highlight Broad Pipeline at ENDO 2023 - Vimarsana News

Crinetics to Highlight Broad Pipeline at ENDO 2023

Endocrine Society President to Present Crinetics CEO with John D. Baxter Prize for EntrepreneurshipSAN DIEGO, June 09, 2023 -- Crinetics Pharmaceuticals, Inc. today announced upcoming... | June 9, 2023

Crinetics Pharmaceuticals Announces Inducement Grants Under - Vimarsana News

Crinetics Pharmaceuticals Announces Inducement Grants Under

SAN DIEGO, May 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the...